In the sterile, professional environment of Jean Hailes for Women’s Health clinics, Chief Executive Officer Sarah White has observed a burgeoning and troubling trend. Increasing numbers of women in their 30s are arriving at her clinics, convinced they are entering perimenopause. While the transition toward menopause can indeed begin as early as 30, it typically does not manifest until the mid-40s. Yet, for this new generation of patients, every bout of fatigue, every mood swing, and every sleepless night is immediately attributed to the hormonal shift.
White’s concern is not merely about medical accuracy; it is about the "narrow focus" that is shifting attention away from other critical health issues. This phenomenon is part of a broader, more systemic shift: the transformation of a natural biological life stage into a looming medical emergency. Driven by a combination of social media algorithms, commercial opportunism, and a medical establishment prone to over-prescription, menopause is being "medicalized" in a way that may be doing women more harm than good.
Main Facts: The Rise of ‘Meno-Washing’
The term "meno-washing" has emerged to describe the practice of brands associating mundane products—from tea and chocolate to socks and skin creams—with menopause to justify premium pricing. This commercialization relies on a specific narrative: that menopause is a devastating, all-encompassing condition that requires a suite of specialized products to manage.
At the heart of this issue are several key realities:
- Symptom Inflation: While scientific research clearly links only two primary symptoms—vaginal dryness and vasomotor symptoms (hot flashes)—to menopause, popular discourse now attributes over 200 different symptoms to the transition.
- The Antidepressant Pivot: When women seek help for the "midlife collision" of stress and exhaustion, they are frequently prescribed antidepressants. In the U.S., women in their 40s and 50s have the highest rates of antidepressant use, despite these drugs often being used as "band-aids" for situational distress rather than clinical depression.
- Narrative Hijacking: Experts argue that commercial entities have stepped into a historical vacuum of women’s health research, positioning themselves as "allies" to sell products rather than advocating for systemic policy changes.
Chronology: From Taboo to ‘Hot Flush Gold Rush’
For decades, menopause was a "silent" transition, rarely discussed in public or adequately addressed in medical curricula. However, the last decade has seen a radical shift.
The Social Media Catalyst
The transition’s recent visibility is a double-edged sword. While breaking the taboo is inherently positive, social media algorithms have favored "formidable" portrayals of the experience. Martha Hickey, Professor of Obstetrics and Gynaecology at the University of Melbourne, notes that a Google image search for "menopause" returns a bleak gallery of women fanning themselves in distress or appearing to lose consciousness. These exaggerated angles are amplified by algorithms because they incite intense emotion, creating a feedback loop of fear for younger women.
The Transition of Advocacy to Industry
Sarah White, who previously served as the director of the Australian tobacco control program, Quit, sees eerie parallels between the tobacco industry’s tactics and current menopause marketing. Just as tobacco companies once marketed "safety" to lure customers, health brands are now "hijacking the narrative" to create a sense of necessity.
By the early 2020s, menopause had become a "hot flush gold rush." Middle-aged women, who often possess more disposable income than younger demographics, became the primary targets for "menopause-friendly" accreditations and luxury supplements. This shift moved menopause from a private biological event to a centrally defining identity, often characterized by a "productivity cliff" that threatens a woman’s professional standing.
Supporting Data: The Science vs. The Marketing
The gap between clinical evidence and commercial claims is widening. According to research published in The Lancet, the scientific consensus remains narrow regarding what can be definitively blamed on declining estrogen.
The Over-Prescription Crisis
Because menopause is framed as a psychiatric and physiological breakdown, the pharmaceutical response has been aggressive:
- Antidepressant Use: Women are 2.5 times more likely to use antidepressants than men. Use peaks during the menopausal years.
- Health Risks: For women over 45, these prescriptions carry heightened risks. Antidepressants have been linked to an increased risk of bone fractures and cardiovascular events—conditions that post-menopausal women are already naturally more vulnerable to.
- Misapplied HRT: Hormone Replacement Therapy (HRT) is highly effective for hot flashes and night sweats. However, experts like Professor Hickey warn that it is increasingly being prescribed for a host of other "menopause-branded" symptoms it cannot actually treat.
The Cultural Variable
Perhaps the most damning evidence against the "universal medical emergency" narrative is the vast cross-cultural variation in symptoms.
- The "Second Spring": In China, menopause is often referred to as a "second spring," a time of rebirth. Research indicates Chinese women report significantly fewer symptoms and lower distress than Western women.
- Indigenous Perspectives: In many indigenous cultures, where menopause is seen as a transition to a respected elder status, vasomotor symptoms (hot flashes) are notably less common.
- The Migration Study: A 2009 study compared Indian women in Delhi with those who had migrated to the UK. The migrants reported symptoms more closely aligned with the medicalized UK experience than with their counterparts in India, suggesting that cultural expectations—rather than just biology—drive the physical experience of menopause.
Official Responses and Expert Perspectives
Regulatory bodies and sociologists are beginning to push back against the "meno-washing" of the economy. Sarah White, as part of the Women’s Health Products Working Group for Australia’s Therapeutic Goods Administration (TGA), is actively monitoring the rise of questionable health products.
The Burden of "Empowerment"
Sociologist Emine Öncüler Yayalar and marketing researcher Ayse Öncüler have identified two primary messaging strategies used by brands: "Empowerment" and "Care."
- The Empowerment Trap: By telling a woman she is the "main actor" in her menopause, brands shift the burden onto her to "optimize" her body through consumption.
- The Care Façade: Brands portray themselves as the only entities that truly "understand" women, filling a gap left by a medical establishment that has historically ignored female-specific health.
"It’s kind of interesting," Yayalar notes, "because both of these actually put the burden on the woman." The solution offered is always individualistic: buy a product, take a pill, or fix the problem within yourself, rather than questioning the external pressures of midlife.
The Workplace Bias
White is particularly scathing regarding "menopause-friendly" workplace training packages. To sell these packages, companies often present "bad data" suggesting women become less productive during menopause. In reality, middle-aged women are a highly productive subpopulation. By framing menopause as a "danger" to the bottom line, even well-intentioned employers may develop unconscious biases against hiring or promoting women in their 40s and 50s.
Implications: Reclaiming the Narrative
The medicalization of menopause creates a self-fulfilling prophecy. Psychological research shows that "catastrophizing"—focusing on the worst possible outcomes—actually increases the perceived severity of physical symptoms. Distress about hot flashes is more strongly linked to the frequency of negative thoughts about them than the actual frequency of the flashes themselves.
The Role of Cognitive Behavioral Therapy (CBT)
Experts suggest that instead of a "pill for every ill," many women would benefit from Cognitive Behavioral Therapy (CBT). Much like its use in chronic pain management, CBT doesn’t make the physical sensation disappear, but it helps women "restructure" their thinking, making the symptoms manageable and reducing the emotional toll.
A New Educational Standard
The path forward requires a decoupling of health education from commercial interest. Sarah White and Martha Hickey argue for:
- Industry-Free Resources: Education that is not sponsored by pharmaceutical or supplement companies.
- Preparation, Not Fear: Shifting the mantra to "be prepared, but not scared."
- Acknowledging the "Midlife Collision": Recognizing that the real "symptoms" of midlife are often the result of structural issues: the "sandwich generation" burden of caring for elderly parents and children simultaneously, financial instability, and gendered ageism in the workplace.
As White puts it, "It’s the structural things we need to change, not just taking a pill that’s suddenly going to make everything all right."
Ultimately, the goal is to view menopause with the same nuance we afford pregnancy: a normal biological event that is usually fine, but which requires medical support when—and only when—it goes wrong. By stripping away the "meno-washing" and the catastrophic narratives, society can allow women to approach their "second spring" with the respect and agency they deserve, rather than as consumers in a manufactured medical crisis.
